Market positioning: Semaglutide is becoming more affordable with generics, whereas tirzepatide (by Eli Lilly) remains a premium, patented therapy
Payment Shopping has never been easier with our flexible payment options
How does my RxSaveCard work
When CKD reaches an advanced stage, dangerous levels of fluid, electrolytes, and wastes can build up in the body
Key research findings include: GLP-1 medications do not prevent the natural reduction in resting energy expenditure that accompanies weight loss The primary mechanism remains caloric restriction through enhanced satiety Improvements in metabolic health markers (insulin sensitivity, lipid profiles) occur secondary to weight loss rather than direct metabolic stimulation No evidence supports claims that these medications 'reset' or permanently increase baseline metabolism For lipotropic injections, high-quality randomised controlled trials are notably absent
RY: Supervision, Writing review & editing